Company Filing History:
5 out of 735 
4 out of 49 Years Active: 2013-2020
Title: Jaeki Min: Innovator in Histone Deacetylase Inhibitors
Introduction
Jaeki Min is a prominent inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit histone deacetylase 6 (HDAC6). With a total of nine patents to his name, Min's work is paving the way for new therapeutic options.
Latest Patents
Among his latest patents are the 1,3,4-oxadiazole sulfonamide derivative compounds, which serve as histone deacetylase 6 inhibitors. These novel compounds are represented by a specific formula and exhibit HDAC6 inhibitory activity. They are designed for use in therapeutic medicaments and pharmaceutical compositions. The compounds are effective in treating a variety of diseases, including infectious diseases, neoplasms, and neurological disorders. The invention also includes methods for preparing these compounds and their use in treating HDAC6-mediated diseases.
Career Highlights
Jaeki Min has worked with notable companies in the pharmaceutical industry, including SK Innovation Co., Ltd. and Chong Kun Dang Pharmaceutical Corporation. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Min has collaborated with several professionals in his field, including Myungahn Ok and Jisu Jeong, who is a woman. These collaborations have likely enhanced his research and development efforts.
Conclusion
Jaeki Min's innovative work in the field of histone deacetylase inhibitors showcases his commitment to advancing medical science. His contributions are expected to have a lasting impact on the treatment of various diseases.